These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 17140358

  • 1. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance.
    Doern GV.
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):821-35. PubMed ID: 17140358
    [Abstract] [Full Text] [Related]

  • 2. Barriers to the effective management of respiratory tract infections in the community.
    Saginur R.
    Infection; 2001 Dec; 29 Suppl 2():3-10. PubMed ID: 11785853
    [Abstract] [Full Text] [Related]

  • 3. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
    Lode H.
    Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial drug use and resistance among respiratory pathogens in the community.
    Low DE.
    Clin Infect Dis; 2001 Sep 15; 33 Suppl 3():S206-13. PubMed ID: 11524720
    [Abstract] [Full Text] [Related]

  • 5. Short-duration therapy for respiratory tract infections.
    Goff DA.
    Ann Pharmacother; 2004 Sep 15; 38(9 Suppl):S19-23. PubMed ID: 15226490
    [Abstract] [Full Text] [Related]

  • 6. Antibiotic resistance in community-acquired respiratory tract infections: current issues.
    Spach DH, Black D.
    Ann Allergy Asthma Immunol; 1998 Oct 15; 81(4):293-302; quiz 302-3. PubMed ID: 9809491
    [Abstract] [Full Text] [Related]

  • 7. Primary care challenges in the management of respiratory tract infections.
    JAAPA; 2006 Sep 15; Suppl():4-14; quiz 15-6. PubMed ID: 17001773
    [Abstract] [Full Text] [Related]

  • 8. Clinical impact of antibiotic resistance in respiratory tract infections.
    Klugman KP.
    Int J Antimicrob Agents; 2007 Feb 15; 29 Suppl 1():S6-10. PubMed ID: 17307654
    [Abstract] [Full Text] [Related]

  • 9. Managing acute lower respiratory tract infections in an era of antibacterial resistance.
    Volturo GA, Low DE, Aghababian R.
    Am J Emerg Med; 2006 May 15; 24(3):329-42. PubMed ID: 16635707
    [Abstract] [Full Text] [Related]

  • 10. Meeting the challenge of antibiotic resistance: The PROTEKT US study.
    Stratton CW.
    Postgrad Med; 2002 Sep 15; 112(3 Suppl):7-11. PubMed ID: 19667589
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of empirical prescribing of antimicrobials in community-acquired pneumonia in three countries in the presence of resistance.
    Martin M, Quilici S, File T, Garau J, Kureishi A, Kubin M.
    J Antimicrob Chemother; 2007 May 15; 59(5):977-89. PubMed ID: 17395688
    [Abstract] [Full Text] [Related]

  • 12. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP, Zhanel GG.
    Semin Respir Crit Care Med; 2009 Apr 15; 30(2):210-38. PubMed ID: 19296420
    [Abstract] [Full Text] [Related]

  • 13. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
    Hoban DJ, Zhanel GG.
    Expert Rev Anti Infect Ther; 2006 Dec 15; 4(6):973-80. PubMed ID: 17181414
    [Abstract] [Full Text] [Related]

  • 14. Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections.
    Calbo E, Garau J.
    Respiration; 2005 Dec 15; 72(6):561-71. PubMed ID: 16354997
    [Abstract] [Full Text] [Related]

  • 15. Treatment recommendations for patients with common respiratory tract infections with variables indicative of treatment failure.
    Basri RS, Weiland DA, Ledgerwood GL.
    J Fam Pract; 2008 Feb 15; 57(2 Suppl Managing):S19-23. PubMed ID: 18662525
    [Abstract] [Full Text] [Related]

  • 16. [Infections and bacterial resistance in the community].
    Goettsch WG, Goossens H, de Neeling AJ, Sprenger MJ.
    Ned Tijdschr Geneeskd; 1999 Jun 19; 143(25):1296-9. PubMed ID: 10416482
    [Abstract] [Full Text] [Related]

  • 17. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM.
    Infection; 2005 Jun 19; 33(3):106-14. PubMed ID: 15940410
    [Abstract] [Full Text] [Related]

  • 18. The evolution of antimicrobial agents used for the management of CARTIs: a focus on a new class of antimicrobials--the ketolides.
    Sbarbaro JA.
    Am J Manag Care; 2004 Oct 19; 10(12 Suppl):S389-99. PubMed ID: 15603248
    [No Abstract] [Full Text] [Related]

  • 19. Clinical efficacy of newer agents in short-duration therapy for community-acquired pneumonia.
    File TM.
    Clin Infect Dis; 2004 Sep 01; 39 Suppl 3():S159-64. PubMed ID: 15546111
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.